Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
healthcare
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
archive
babies
bio-repository
biotech
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
cholesterol
clinical hold
clinical study
clinical trials
column
combination
commissioner
congress
coronavirus
crispr
crispr-cas9
cybersecurity
data
delisting
democrats
What
big
5
×
ceo
5
×
medicine
bio
company
drug
read
week
according
aces
addressed
akin
announced
answers
biggest
blood
bosley's
bosley’s
breach
bridge
bucks
cas
cholesterol
companies
cost
covid
create
crime
crispr
crowdsourced
cybersecurity
departure
disruptive
diverse
early
editas
exit
fact
flexible
founder
Language
unset
Current search:
medicine���s
×
big
×
ceo
×
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@techcrunch.com
7 years ago
Regenerative medicine today is like the internet in 1993
@techcrunch.com
9 years ago
This Cybersecurity Medicine Might Be Tough To Swallow